Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-infected individuals in Brazil

被引:6
作者
Diaz, Ricardo Sobhie [1 ]
Vasconcelos, Lucy [2 ]
Hayden, Ricardo L. [3 ]
Tenore, Simone [1 ]
Turcato, Gilberto, Jr. [1 ]
Palacios, Ricardo [1 ]
Sucupira, Maria C. [1 ]
机构
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Prefeitura Municipal Sao Paulo, Sao Paulo, Brazil
[3] Santa Casa Santos, Santos, Brazil
关键词
D O I
10.1097/QAI.0b013e31815b0d48
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:399 / 401
页数:3
相关论文
共 8 条
[1]  
Accetturi CA, 2000, J ACQ IMMUN DEF SYND, V24, P399, DOI 10.1097/00126334-200008010-00016
[2]  
Ananworanich J, 2006, ANTIVIR THER, V11, P631
[3]   High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil [J].
Araripe Sucupira, Maria Cecilia ;
Caseiro, Marcos Montani ;
Alves, Katia ;
Tescarollo, Graziela ;
Janini, Luiz Mario ;
Sabino, Ester Cerdeira ;
Castelo, Adauto ;
Page-Shafer, Kim ;
Diaz, Ricardo Sobhie .
AIDS PATIENT CARE AND STDS, 2007, 21 (02) :116-128
[4]   Lopinavir/ritonavir as single-drug therapy for maintenance of HlV-1 viral suppression -: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK study) [J].
Arribas, JR ;
Pulido, F ;
Delgado, R ;
Lorenzo, A ;
Miralles, P ;
Arranz, A ;
González-García, JJ ;
Cepeda, C ;
Hervás, R ;
Paño, JR ;
Gaya, F ;
Carcas, A ;
Montes, ML ;
Costa, JR ;
Peña, JM .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) :280-287
[5]   Low accumulation of L90M in protease from subtype FHIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism [J].
Calazans, A ;
Brindeiro, R ;
Brindeiro, P ;
Verli, H ;
Arruda, MB ;
Gonzalez, LMF ;
Guimaraes, JA ;
Diaz, RS ;
Antunes, OAC ;
Tanuri, A .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (11) :1961-1970
[6]  
De Sá DJ, 2006, AIDS RES HUM RETROV, V22, P1
[7]   The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacovir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial (vol 368, pg 476, 2006) [J].
Eron, Joseph, Jr. ;
Yeni, Patrick ;
Gathe, Joseph .
LANCET, 2006, 368 (9543) :1238-1238
[8]  
Witvrouw M, 2004, ANTIVIR THER, V9, P57